Deborah A. Leonard

651 total citations
22 papers, 503 citations indexed

About

Deborah A. Leonard is a scholar working on Molecular Biology, Surgery and Biochemistry. According to data from OpenAlex, Deborah A. Leonard has authored 22 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Surgery and 3 papers in Biochemistry. Recurrent topics in Deborah A. Leonard's work include Cholesterol and Lipid Metabolism (8 papers), Steroid Chemistry and Biochemistry (7 papers) and Plant biochemistry and biosynthesis (4 papers). Deborah A. Leonard is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Steroid Chemistry and Biochemistry (7 papers) and Plant biochemistry and biosynthesis (4 papers). Deborah A. Leonard collaborates with scholars based in United States, Germany and Canada. Deborah A. Leonard's co-authors include Milton Zaitlin, Leah L. Frye, J M Trzaskos, Kevin P. Cusack, Michael A. Kotarski, Robert T. Fischer, Margaret Favata, Richard A. Cerione, Richard Shaw and Bing Lim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genetics.

In The Last Decade

Deborah A. Leonard

22 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah A. Leonard United States 14 310 116 113 40 38 22 503
Xuan‐Chuan Yu United States 10 342 1.1× 33 0.3× 52 0.5× 53 1.3× 24 0.6× 14 598
Hyung-Rho Kim South Korea 11 195 0.6× 111 1.0× 40 0.4× 11 0.3× 13 0.3× 17 419
J.-F. Brun France 4 236 0.8× 18 0.2× 64 0.6× 31 0.8× 37 1.0× 11 483
Óscar H. Martínez-Costa Spain 14 324 1.0× 48 0.4× 48 0.4× 88 2.2× 15 0.4× 28 514
Angela Bisso Italy 9 361 1.2× 26 0.2× 29 0.3× 14 0.3× 15 0.4× 10 529
Weimei Sun United States 14 493 1.6× 64 0.6× 15 0.1× 18 0.5× 21 0.6× 24 647
Emil Schiltz Germany 15 462 1.5× 39 0.3× 59 0.5× 9 0.2× 46 1.2× 25 666
Y.H. Liau United States 12 313 1.0× 32 0.3× 121 1.1× 9 0.2× 23 0.6× 44 489
Wayne N. Yunghans United States 7 207 0.7× 18 0.2× 72 0.6× 11 0.3× 49 1.3× 13 372

Countries citing papers authored by Deborah A. Leonard

Since Specialization
Citations

This map shows the geographic impact of Deborah A. Leonard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Leonard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Leonard more than expected).

Fields of papers citing papers by Deborah A. Leonard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Leonard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Leonard. The network helps show where Deborah A. Leonard may publish in the future.

Co-authorship network of co-authors of Deborah A. Leonard

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah A. Leonard. A scholar is included among the top collaborators of Deborah A. Leonard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah A. Leonard. Deborah A. Leonard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Williams, Brent A., Joan M. Dorn, Michael J. LaMonte, et al.. (2012). Evaluating the Prognostic Value of Positron‐Emission Tomography Myocardial Perfusion Imaging Using Automated Software to Calculate Perfusion Defect Size. Clinical Cardiology. 35(11). E14–21. 9 indexed citations
3.
Leonard, Deborah A., et al.. (2011). Elevated expression of the interleukin-8 receptors CXCR1 and CXCR2 in peripheral blood cells in obstructive coronary artery disease. Coronary Artery Disease. 22(7). 491–496. 17 indexed citations
4.
Leonard, Deborah A., et al.. (2010). “When It's More Than the Blues”: A Collaborative Response to Postpartum Depression. Public Health Nursing. 27(3). 248–254. 10 indexed citations
5.
Frye, Leah L. & Deborah A. Leonard. (1999). Lanosterol Analogs: Dual-Action Inhibitors of Cholesterol Biosynthesis. Critical Reviews in Biochemistry and Molecular Biology. 34(2). 123–140. 29 indexed citations
6.
Kotarski, Michael A., et al.. (1998). TheDrosophilageneasteroidencodes a novel protein and displays dosage-sensitive interactions withStarandEgfr. Genome. 41(2). 295–302. 12 indexed citations
7.
8.
Anderson, J. Ansel, Deborah A. Leonard, Kevin P. Cusack, & Leah L. Frye. (1995). 15-Substituted Lanosterols: Post-transcriptional Suppressors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase. Archives of Biochemistry and Biophysics. 316(1). 190–196. 11 indexed citations
9.
Leonard, Deborah A., et al.. (1994). Post-transcriptional Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme-A Reductase by 3β-Hydroxy-Lanost-8-en-32-Al, an Intermediate in the Conversion of Lanosterol to Cholesterol. Archives of Biochemistry and Biophysics. 310(1). 152–157. 27 indexed citations
10.
Frye, Leah L., Kevin P. Cusack, Deborah A. Leonard, & J. Ansel Anderson. (1994). Oxolanosterol oximes: dual-action inhibitors of cholesterol biosynthesis.. Journal of Lipid Research. 35(8). 1333–1344. 14 indexed citations
11.
Frye, Leah L., Kevin P. Cusack, & Deborah A. Leonard. (1993). 32-Methyl-32-oxylanosterols: dual-action inhibitors of cholesterol biosynthesis. Journal of Medicinal Chemistry. 36(3). 410–416. 22 indexed citations
12.
Trzaskos, J M, Ronald L. Magolda, Margaret Favata, et al.. (1993). Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.. Journal of Biological Chemistry. 268(30). 22591–22599. 39 indexed citations
13.
Leonard, Deborah A., et al.. (1988). An ATP-dependent system specific for degradation of long-lived proteins in permeabilized cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 968(3). 269–274. 3 indexed citations
14.
Leonard, Deborah A., et al.. (1987). ATP-dependent degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in permeabilized cells.. Journal of Biological Chemistry. 262(16). 7914–7919. 36 indexed citations
15.
Leonard, Deborah A., et al.. (1984). Aphidicolin, a specific inhibitor of DNA polymerase alpha, inhibits conversion of lanosterol to C-27 sterols in mouse L cells.. Journal of Biological Chemistry. 259(8). 4904–4909. 8 indexed citations
16.
Leonard, Deborah A., et al.. (1984). Chloroquine inhibits cyclization of squalene oxide to lanosterol in mammalian cells.. Journal of Biological Chemistry. 259(13). 8156–8162. 40 indexed citations
17.
Kotarski, Michael A., et al.. (1983). THE CHARACTERIZATION OF α-GLYCEROPHOSPHATE DEHYDROGENASE MUTANTS IN DROSOPHILA MELANOGASTER. Genetics. 105(2). 387–407. 26 indexed citations
18.
Leonard, Deborah A. & Milton Zaitlin. (1982). A temperature-sensitive strain of tobacco mosaic virus defective in cell-to-cell movement generates an altered viral-coded protein. Virology. 117(2). 416–424. 83 indexed citations
19.
Zelcer, Aaron, et al.. (1981). Plant cell suspension cultures sustain long-term replication of potato spindle tuber viroid. Virology. 109(2). 314–322. 21 indexed citations
20.
Leonard, Deborah A., et al.. (1975). In vivo synthesis and turnover of cytoplasmic ribosomal RNA by stage 6 oocytes of Xenopus laevis. Developmental Biology. 45(1). 199–202. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuan‐Chuan Yu Breakdown of academic impact, for papers by Hyung-Rho Kim Breakdown of academic impact, for papers by J.-F. Brun Breakdown of academic impact, for papers by Óscar H. Martínez-Costa Breakdown of academic impact, for papers by Angela Bisso Breakdown of academic impact, for papers by Weimei Sun Breakdown of academic impact, for papers by Emil Schiltz Breakdown of academic impact, for papers by Y.H. Liau Breakdown of academic impact, for papers by Wayne N. Yunghans
Rankless by CCL
2026